Answers are grounded in this paper and cite their sources.
The paired synthesis of skeletally distinct polycyclic isomers has traditionally relied on separate and tailored synthetic designs, whereas their direct interconversion ranks among the most challenging transformations even within the realm of skeletal editing. However, we introduce that solvent‑controlled skeletal disproportionation, despite its scarcity, offers a convenient means to formally achieve such atom‑conserving skeletal reorganization. We exemplify this strategy with the copper‑catalyzed aerobic oxidation of readily available diarylamines, arylglyoxals, and alkenes: the addition of a few drops of hexafluoroisopropanol (HFIP) to a 1,2-dichloroethane (DCE, 2.0 mL) suffice to trigger a complete selectivity flip in product skeletons. This “butterfly effect” leverages a switchable synthesis of two non-interconvertible, yet pharmaceutically privileged isomers—6/5/6/6 tetracyclic indolo[1,2- a ]quinolines and 6/6 semi-saturated 2-acyl-1,4-dihydroquinolines, whose structural divergence is quantified by an average Tanimoto coefficient of 0.45. DFT calculations reveal that HFIP resolves the inherent regioselectivity conundrum between electron-rich arylamines and dicarbonyl electrophiles by reshaping the ring-size of competing transition states through hydrogen bonding, thereby redirecting chemoselectivity at the onset of the domino process. Biological evaluation across three cancer cell lines shows that this solvent-controlled skeletal divergence directly yields pronounced bioactivity bifurcation between the two isomers. This strategy allows the parallel expansion of compound libraries and would accelerate biological evaluation through a single synthetic design.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: